{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:16:12Z","timestamp":1793470572625,"version":"4.5.0"},"reference-count":168,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Surgery"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.cpsurg.2023.101361","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T15:47:03Z","timestamp":1688658423000},"page":"101361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Biology and Management of Ductal Carcinoma in Situ of the Breast"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6775-0039","authenticated-orcid":false,"given":"Ismail","family":"Jatoi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer M.","family":"Shaaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Jou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpsurg.2023.101361_bib0001","doi-asserted-by":"crossref","first-page":"40","DOI":"10.14694\/EdBook_AM.2012.32.228","article-title":"Ductal carcinoma in situ: challenges, opportunities, and uncharted waters","author":"Hoffman","year":"2012","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.cpsurg.2023.101361_bib0002","series-title":"StatPearls [Internet]","article-title":"Breast ductal carcinoma in situ","author":"Tomlinson-Hansen","year":"2023"},{"issue":"1","key":"10.1016\/j.cpsurg.2023.101361_bib0003","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/his.14804","article-title":"Identifying recurrences and metastasis after ductal carcinoma in situ (DCIS) of the breast","volume":"82","author":"Udayasiri","year":"2023","journal-title":"Histopathology"},{"issue":"13","key":"10.1016\/j.cpsurg.2023.101361_bib0004","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1002\/cam4.3112","article-title":"Albert C. Broders, tumor grading, and the origin of the long road to personalized cancer care","volume":"9","author":"Wright","year":"2020","journal-title":"Cancer Med"},{"issue":"11","key":"10.1016\/j.cpsurg.2023.101361_bib0005","first-page":"311","article-title":"Carcinoma of the breast (including carcinoma in situ) and its grades of malignancy and prognosis","volume":"49","author":"Broders","year":"1953","journal-title":"W V Med J"},{"issue":"5","key":"10.1016\/j.cpsurg.2023.101361_bib0006","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/jnci\/50.5.1111","article-title":"On the origin and progression of ductal carcinoma in the human breast","volume":"50","author":"Wellings","year":"1973","journal-title":"J Natl Cancer Inst"},{"issue":"4 Suppl","key":"10.1016\/j.cpsurg.2023.101361_bib0007","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/1097-0142(19800815)46:4+<919::AID-CNCR2820461311>3.0.CO;2-Z","article-title":"The clinical significance of pre-invasive breast carcinoma","volume":"46","author":"Rosen","year":"1980","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.cpsurg.2023.101361_bib0008","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/cncr.20979","article-title":"Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study","volume":"103","author":"Collins","year":"2005","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.cpsurg.2023.101361_bib0009","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2214\/AJR.17.18778","article-title":"Ductal carcinoma in situ: the whole truth","volume":"210","author":"Parikh","year":"2018","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.cpsurg.2023.101361_bib0010","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/jnci\/djr027","article-title":"Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS","volume":"103","author":"Wapnir","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"5 Suppl","key":"10.1016\/j.cpsurg.2023.101361_bib0011","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.21614\/chirurgia.116.5.suppl.S7","article-title":"The natural history of ductal carcinoma in situ of the breast - an overview","volume":"116","author":"Fredholm","year":"2021","journal-title":"Chirurgia (Bucur)"},{"issue":"4","key":"10.1016\/j.cpsurg.2023.101361_bib0012","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","article-title":"Ductal carcinoma in situ: to treat or not to treat, that is the question","volume":"121","author":"van Seijen","year":"2019","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.cpsurg.2023.101361_bib0013","article-title":"Are we further reducing breast cancer mortality the more intensively we screen?\"","volume":"45","year":"2019","journal-title":"The Cancer Letter"},{"issue":"6","key":"10.1016\/j.cpsurg.2023.101361_bib0014","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jamcollsurg.2019.01.018","article-title":"Twenty-five year trends in the incidence of ductal carcinoma in situ in US women","volume":"228","author":"Oseni","year":"2019","journal-title":"J Am Coll Surg"},{"issue":"2","key":"10.1016\/j.cpsurg.2023.101361_bib0015","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2214\/AJR.19.22025","article-title":"Nipple discharge: current clinical and imaging evaluation","volume":"216","author":"Gupta","year":"2021","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"10.1016\/j.cpsurg.2023.101361_bib0016","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1177\/000313481307901011","article-title":"Paget's disease of the nipple with parenchymal ductal carcinoma in situ is associated with worse prognosis than Paget's disease alone","volume":"79","author":"Durkan","year":"2013","journal-title":"Am Surg"},{"issue":"10","key":"10.1016\/j.cpsurg.2023.101361_bib0017","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.3390\/cancers14102422","article-title":"Mammary Paget's disease: an update","volume":"14","author":"Markarian","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.cpsurg.2023.101361_bib0018","first-page":"4","article-title":"Breast ductal carcinoma in situ in an unscreened population: presentation, diagnosis and management at a single tertiary centre","volume":"55","author":"Mutebi","year":"2017","journal-title":"S Afr J Surg"},{"key":"10.1016\/j.cpsurg.2023.101361_bib0019","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.sopen.2022.12.002","article-title":"Is palpable DCIS more aggressive than screen-detected DCIS?","volume":"11","author":"Balac","year":"2023","journal-title":"Surg Open Sci"},{"issue":"3","key":"10.1016\/j.cpsurg.2023.101361_bib0020","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jnci\/djp482","article-title":"Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes","volume":"102","author":"Virnig","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cpsurg.2023.101361_bib0021","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fonc.2017.00248","article-title":"Ductal carcinoma in situ biology, biomarkers, and diagnosis. Review","volume":"7","author":"Gorringe","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.cpsurg.2023.101361_bib0022","unstructured":"Cancer Research UK. In situ breast carcinoma incidence statistics. Accessed Jan 23, 2017. www.cancerresearch.uk.org"},{"issue":"6","key":"10.1016\/j.cpsurg.2023.101361_bib0023","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/CCO.0000000000000769","article-title":"Are advancements in screening technology contributing to breast cancer over-diagnosis?","volume":"33","author":"Jatoi","year":"2021","journal-title":"Curr Opin Oncol"},{"issue":"7","key":"10.1016\/j.cpsurg.2023.101361_bib0024","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/ijc.28803","article-title":"Is carcinoma in situ a precursor lesion of invasive breast cancer?","volume":"135","author":"To","year":"2014","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.cpsurg.2023.101361_bib0025","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/bjc.1987.296","article-title":"Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies","volume":"56","author":"Nielsen","year":"1987","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.cpsurg.2023.101361_bib0026","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0046-8177(85)80251-3","article-title":"The prevalence of carcinoma in situ in normal and cancer-associated breasts","volume":"16","author":"Alpers","year":"1985","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.cpsurg.2023.101361_bib0027","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/ije\/18.2.295","article-title":"Evaluation of overdiagnosis of breast cancer in screening with mammography: results of the Nijmegen programme","volume":"18","author":"Peeters","year":"1989","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.cpsurg.2023.101361_bib0028","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0039-6060(05)80019-4","article-title":"Mammographically detected ductal carcinoma in situ: are we overdiagnosing breast cancer?","volume":"118","author":"Jatoi","year":"1995","journal-title":"Surgery"},{"issue":"7","key":"10.1016\/j.cpsurg.2023.101361_bib0029","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","article-title":"Breast cancer mortality after a diagnosis of ductal carcinoma in situ","volume":"1","author":"Narod","year":"2015","journal-title":"JAMA Oncol"},{"issue":"7","key":"10.1016\/j.cpsurg.2023.101361_bib0030","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/archinte.160.7.953","article-title":"Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program","volume":"160","author":"Ernster","year":"2000","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.cpsurg.2023.101361_bib0031","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.17124","article-title":"Association of a diagnosis of ductal carcinoma in situ with death from breast cancer","volume":"3","author":"Giannakeas","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.cpsurg.2023.101361_bib0032","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jtbi.2004.08.002","article-title":"Evaluation of pathways for progression of heterogeneous breast tumors","volume":"232","author":"Sontag","year":"2005","journal-title":"J Theor Biol"},{"issue":"1","key":"10.1016\/j.cpsurg.2023.101361_bib0033","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10549-017-4644-3","article-title":"Is invasion a necessary step for metastases in breast cancer?","volume":"169","author":"Narod","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.cpsurg.2023.101361_bib0034","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.1100","article-title":"Association of radiotherapy with survival in women treated for ductal carcinoma in situ with lumpectomy or mastectomy","volume":"1","author":"Giannakeas","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cpsurg.2023.101361_bib0035","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41523-018-0061-y","article-title":"Hypothesis: can the abscopal effect explain the impact of adjuvant radiotherapy on breast cancer mortality?","volume":"4","author":"Jatoi","year":"2018","journal-title":"NPJ Breast Cancer"},{"issue":"3","key":"10.1016\/j.cpsurg.2023.101361_bib0036","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s10549-011-1478-2","article-title":"Hematogenous and lymphatic tumor cell dissemination may be detected in patients diagnosed with ductal carcinoma in situ of the breast","volume":"131","author":"Banys","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"10.1016\/j.cpsurg.2023.101361_bib0037","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1002\/ijc.25895","article-title":"Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ","volume":"129","author":"Sanger","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cpsurg.2023.101361_bib0038","first-page":"171","article-title":"Intermediate histological effect markers for breast cancer","volume":"154","author":"Miller","year":"2001","journal-title":"IARC Sci Publ"},{"issue":"7","key":"10.1016\/j.cpsurg.2023.101361_bib0039","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.3390\/curroncol29070392","article-title":"Countercurrents: DCIS or Cancer? Why all the confusion?","volume":"29","author":"Narod","year":"2022","journal-title":"Curr Oncol"},{"issue":"2","key":"10.1016\/j.cpsurg.2023.101361_bib0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3122\/jabfm.19.2.161","article-title":"BI-RADS classification for management of abnormal mammograms","volume":"19","author":"Eberl","year":"2006","journal-title":"J Am Board Fam Med"},{"issue":"1","key":"10.1016\/j.cpsurg.2023.101361_bib0041","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1524-4741.2009.00863.x","article-title":"Clinical implications of subcategorizing BI-RADS 4 breast lesions associated with microcalcification: a radiology-pathology correlation study","volume":"16","author":"Sanders","year":"2010","journal-title":"Breast J"},{"issue":"1","key":"10.1016\/j.cpsurg.2023.101361_bib0042","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1148\/radiol.210407","article-title":"Prediction of upstaging in ductal carcinoma in situ based on mammographic radiomic features","volume":"303","author":"Hou","year":"2022","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.cpsurg.2023.101361_bib0043","first-page":"1","article-title":"NIH state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ (DCIS)","volume":"26","author":"Allegra","year":"2009","journal-title":"NIH Consens State Sci Statements"},{"key":"10.1016\/j.cpsurg.2023.101361_bib0044","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev-med-050715-104920","article-title":"Controversies in the treatment of ductal carcinoma in situ","volume":"68","author":"Barrio","year":"2017","journal-title":"Annu Rev Med"},{"issue":"12","key":"10.1016\/j.cpsurg.2023.101361_bib0045","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1245\/s10434-016-5449-z","article-title":"Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In Situ","volume":"23","author":"Morrow","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.cpsurg.2023.101361_bib0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2014.06.011","article-title":"Radiotherapy in DCIS, an underestimated benefit?","volume":"112","author":"Cutuli","year":"2014","journal-title":"Radiother Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.cpsurg.2023.101361_bib0047","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S0960-9776(19)31121-X","article-title":"Estimating the magnitude of clinical benefit of systemic therapy in patients with DCIS or pre-invasive disease of the breast","volume":"48","author":"Lazzeroni","year":"2019","journal-title":"Breast"},{"issue":"41","key":"10.1016\/j.cpsurg.2023.101361_bib0048","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/jncimonographs\/lgq032","article-title":"The impact of surgery on ductal carcinoma in situ outcomes: the use of mastectomy","volume":"2010","author":"Hwang","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"2","key":"10.1016\/j.cpsurg.2023.101361_bib0049","doi-asserted-by":"crossref","first-page":"zrac022","DOI":"10.1093\/bjsopen\/zrac022","article-title":"Sentinel lymph node biopsy in patients with ductal carcinoma in situ: systematic review and meta-analysis","volume":"6","author":"Davey","year":"2022","journal-title":"BJS Open"},{"issue":"18","key":"10.1016\/j.cpsurg.2023.101361_bib0050","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1002\/cncr.32200","article-title":"Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ","volume":"125","author":"Liu","year":"2019","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.cpsurg.2023.101361_bib0051","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ejso.2022.04.005","article-title":"The positive predictive value of vacuum assisted biopsy (VAB) in predicting final histological diagnosis for breast lesions of uncertain malignancy (B3 lesions): a systematic review & meta-analysis","volume":"48","author":"Cullinane","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"10.1016\/j.cpsurg.2023.101361_bib0052","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1038\/s41416-022-01983-4","article-title":"The presentation, management and outcome of patients with ductal carcinoma in situ (DCIS) with microinvasion (invasion \u22641\u2009mm in size)-results from the UK Sloane Project","volume":"127","author":"Shaaban","year":"2022","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.cpsurg.2023.101361_bib0053","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41416-023-02152-x","article-title":"Ductal carcinoma in situ with and without microinvasion: is there a clinically meaningful difference in outcome?","volume":"128","author":"Canas-Marques","year":"2023","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.cpsurg.2023.101361_bib0054","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1245\/s10434-019-07475-9","article-title":"Is sentinel lymph node biopsy required for a core biopsy diagnosis of ductal carcinoma in situ with microinvasion?","volume":"26","author":"Flanagan","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.cpsurg.2023.101361_bib0055","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1245\/s10434-019-08006-2","article-title":"ASO Author Reflections: Is sentinel lymph node biopsy necessary in patients with ductal carcinoma in situ with microinvasion diagnosed on core biopsy?","volume":"27","author":"Phantana-angkool","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.cpsurg.2023.101361_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2021.101557","article-title":"Axillary staging in ductal carcinoma in situ with microinvasion: a meta-analysis","volume":"37","author":"Choi","year":"2021","journal-title":"Surg Oncol"},{"issue":"2","key":"10.1016\/j.cpsurg.2023.101361_bib0057","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1148\/radiol.211839","article-title":"Ductal carcinoma in situ: state-of-the-art review","volume":"302","author":"Grimm","year":"2021","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.cpsurg.2023.101361_bib0058","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3322\/caac.21321","article-title":"Cancer statistics: Breast cancer in situ","volume":"65","author":"Ward","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.cpsurg.2023.101361_bib0059","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.clbc.2013.08.002","article-title":"Palpable ductal carcinoma in situ: analysis of radiological and histological features of a large series with 5-year follow-up","volume":"13","author":"Sundara Rajan","year":"2013","journal-title":"Clin Breast Cancer"},{"issue":"4","key":"10.1016\/j.cpsurg.2023.101361_bib0060","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/his.14725","article-title":"Dataset for pathology reporting of ductal carcinoma in\u2009situ, variants of lobular carcinoma in\u2009situ and low-grade lesions: recommendations from the International Collaboration on Cancer Reporting (ICCR)","volume":"81","author":"Fox","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.cpsurg.2023.101361_sbref0061","series-title":"International Collaboration on Cancer Reporting","article-title":"Ductal Carcinoma In Situ, Variants of Lobular Carcinoma In Situ and Low Grade Lesions Histopathology Reporting Guide","author":"Fox","year":"2017"},{"issue":"5","key":"10.1016\/j.cpsurg.2023.101361_bib0062","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41416-020-01152-5","article-title":"Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project","volume":"124","author":"Shaaban","year":"2021","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.cpsurg.2023.101361_bib0063","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/cjp2.201","article-title":"Variability in grading of ductal carcinoma in situ among an international group of pathologists","volume":"7","author":"van Seijen","year":"2021","journal-title":"J Pathol Clin Res"},{"issue":"3","key":"10.1016\/j.cpsurg.2023.101361_bib0064","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41379-019-0367-9","article-title":"Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study","volume":"33","author":"Dano","year":"2020","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.cpsurg.2023.101361_bib0065","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/s41379-019-0262-4","article-title":"Variability in diagnostic threshold for comedo necrosis among breast pathologists: implications for patient eligibility for active surveillance trials of ductal carcinoma in situ","volume":"32","author":"Harrison","year":"2019","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.cpsurg.2023.101361_bib0066","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s12253-019-00760-8","article-title":"Grading ductal carcinoma in situ (DCIS) of the breast - what's wrong with it?","volume":"26","author":"Cserni","year":"2020","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"10.1016\/j.cpsurg.2023.101361_bib0067","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13000-020-00970-8","article-title":"Grading variation in 2,934 patients with ductal carcinoma in situ of the breast: the effect of laboratory- and pathologist-specific feedback reports","volume":"15","author":"van Dooijeweert","year":"2020","journal-title":"Diagn Pathol"},{"issue":"3","key":"10.1016\/j.cpsurg.2023.101361_bib0068","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12609-021-00415-1","article-title":"Why is LCIS important\u2014pathological review","volume":"13","author":"Shaaban","year":"2021","journal-title":"Curr Breast Cancer Rep"},{"key":"10.1016\/j.cpsurg.2023.101361_bib0069","unstructured":"The Royal College of Pathologists. Guidelines Working Group of the UK National Coordinating Committee for Breast Pathology. Pathology reporting of breast disease in surgical excision specimens incorporating the dataset for histological reporting of breast cancer. Accessed September 1, 2022. https:\/\/www.rcpath.org\/profession\/guidelines\/cancer-datasets-and-tissue-pathways.html."},{"issue":"4","key":"10.1016\/j.cpsurg.2023.101361_bib0070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10911-018-9416-0","article-title":"The emerging roles of steroid hormone receptors in ductal carcinoma in situ (DCIS) of the breast","volume":"23","author":"Villanueva","year":"2018","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"10","key":"10.1016\/j.cpsurg.2023.101361_bib0071","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1158\/1078-0432.CCR-20-4635","article-title":"Prognostic value of ER and PgR expression and the impact of multi-clonal expression for recurrence in ductal carcinoma in situ: results from the UK\/ANZ DCIS trial","volume":"27","author":"Thorat","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.cpsurg.2023.101361_bib0072","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12032-022-01876-9","article-title":"The clinical significance of HER2 expression in DCIS","volume":"40","author":"Akrida","year":"2022","journal-title":"Med Oncol"},{"issue":"6","key":"10.1016\/j.cpsurg.2023.101361_bib0073","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/s41416-020-01216-6","article-title":"Multi-protein spatial signatures in ductal carcinoma in situ (DCIS) of breast","volume":"124","author":"Badve","year":"2021","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.cpsurg.2023.101361_bib0074","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/annonc\/mdw623","article-title":"The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast","volume":"28","author":"Pruneri","year":"2017","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.cpsurg.2023.101361_bib0075","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10549-022-06553-z","article-title":"Clinicopathological characteristics and prognostic analysis of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ (DCIS) and DCIS with microinvasion (DCIS-Mi) of the breast","volume":"193","author":"Jia","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cpsurg.2023.101361_bib0076","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3389\/fonc.2020.01486","article-title":"Tumor-Infiltrating Lymphocytes (TILs) and risk of a second breast event after a ductal carcinoma in situ","volume":"10","author":"Farolfi","year":"2020","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.cpsurg.2023.101361_bib0077","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/his.13217","article-title":"Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ","volume":"71","author":"Miligy","year":"2017","journal-title":"Histopathology"},{"issue":"9","key":"10.1016\/j.cpsurg.2023.101361_bib0078","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/modpathol.2015.79","article-title":"Correlation of histopathologic features of ductal carcinoma in situ of the breast with the oncotype DX DCIS score","volume":"28","author":"Knopfelmacher","year":"2015","journal-title":"Mod Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.cpsurg.2023.101361_bib0079","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41379-020-00665-x","article-title":"Diagnosis of ductal carcinoma in situ in an era of de-escalation of therapy","volume":"34","author":"Schnitt","year":"2021","journal-title":"Mod Pathol"},{"issue":"21","key":"10.1016\/j.cpsurg.2023.101361_bib0080","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1200\/JCO.2006.06.1366","volume":"24","author":"Bijker","year":"2006","journal-title":"J Clin Oncol"},{"issue":"9203","key":"10.1016\/j.cpsurg.2023.101361_bib0081","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0140-6736(99)06341-2","article-title":"Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group","volume":"355","author":"Julien","year":"2000","journal-title":"Lancet"},{"issue":"41","key":"10.1016\/j.cpsurg.2023.101361_bib0082","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jncimonographs\/lgq039","article-title":"Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast","volume":"2010","author":"Correa","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.cpsurg.2023.101361_bib0083","doi-asserted-by":"crossref","first-page":"m1570","DOI":"10.1136\/bmj.m1570","article-title":"Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study","volume":"369","author":"Mannu","year":"2020","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.cpsurg.2023.101361_bib0084","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/his.13837","article-title":"Behaviour and characteristics of low-grade ductal carcinoma in situ of the breast: literature review and single-centre retrospective series","volume":"74","author":"Koh","year":"2019","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.cpsurg.2023.101361_bib0085","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10549-017-4572-2","article-title":"Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ","volume":"167","author":"Sopik","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.cpsurg.2023.101361_bib0086","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jamaoncol.2015.5026","article-title":"Overtreatment of low-grade ductal carcinoma in situ","volume":"2","author":"Fallowfield","year":"2016","journal-title":"JAMA Oncol"},{"issue":"9","key":"10.1016\/j.cpsurg.2023.101361_bib0087","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/jnci\/djy220","article-title":"Cancer outcomes in DCIS patients without locoregional treatment","volume":"111","author":"Ryser","year":"2019","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.cpsurg.2023.101361_bib0088","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-061585","article-title":"Cohort profile of the Sloane Project: methodology for a prospective UK cohort study of >15 000 women with screen-detected non-invasive breast neoplasia","volume":"12","author":"Clements","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.cpsurg.2023.101361_bib0089","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.breast.2022.01.001","article-title":"Unresected screen-detected ductal carcinoma in situ: outcomes of 311 women in the Forget-Me-Not 2 study","volume":"61","author":"Maxwell","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.cpsurg.2023.101361_bib0090","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.breast.2020.09.002","article-title":"Views of healthcare professionals about the role of active monitoring in the management of ductal carcinoma in situ (DCIS): qualitative interview study","volume":"54","author":"Nickel","year":"2020","journal-title":"Breast"},{"issue":"11","key":"10.1016\/j.cpsurg.2023.101361_bib0091","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/ans.13659","article-title":"Not all ductal carcinoma in situ is created equal: can we avoid surgery for low-risk ductal carcinoma in situ?","volume":"86","author":"Lippey","year":"2016","journal-title":"ANZ J Surg"},{"issue":"1","key":"10.1016\/j.cpsurg.2023.101361_bib0092","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00428-021-03173-8","article-title":"Low-risk DCIS. What is it? Observe or excise?","volume":"480","author":"Pinder","year":"2022","journal-title":"Virchows Arch"},{"issue":"15_suppl","key":"10.1016\/j.cpsurg.2023.101361_bib0093","doi-asserted-by":"crossref","first-page":"TPS603","DOI":"10.1200\/JCO.2019.37.15_suppl.TPS603","article-title":"The international collaboration of active surveillance trials for low-risk DCIS (LORIS, LORD, COMET, LORETTA)","volume":"37","author":"Kanbayashi","year":"2019","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.cpsurg.2023.101361_bib0094","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jnci\/djt067","article-title":"A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast","volume":"105","author":"Solin","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.cpsurg.2023.101361_bib0095","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10549-013-2455-8","article-title":"Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis","volume":"138","author":"Rakovitch","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.cpsurg.2023.101361_bib0096","doi-asserted-by":"crossref","first-page":"djw256","DOI":"10.1093\/jnci\/djw256","article-title":"Multigene expression assay and benefit of radiotherapy after breast conservation in ductal carcinoma in situ","volume":"109","author":"Rakovitch","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.cpsurg.2023.101361_bib0097","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10549-018-4693-2","article-title":"Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies","volume":"169","author":"Rakovitch","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.cpsurg.2023.101361_bib0098","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.ajpath.2018.12.003","article-title":"Molecular evaluation of breast ductal carcinoma in situ with oncotype DX DCIS","volume":"189","author":"Nofech-Mozes","year":"2019","journal-title":"Am J Pathol"},{"issue":"10","key":"10.1016\/j.cpsurg.2023.101361_bib0099","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/0959-8049(96)00154-2","article-title":"Comparison of prognostic markers detected by immunohistochemistry in male and female breast carcinomas","volume":"32a","author":"Weber-Chappuis","year":"1996","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.cpsurg.2023.101361_bib0100","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12052036","article-title":"Molecular Signatures in Ductal Carcinoma In Situ (DCIS): A Systematic Review and Meta-Analysis","volume":"12","author":"Ouattara","year":"2023","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.cpsurg.2023.101361_bib0101","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41588-022-01082-3","article-title":"Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer","volume":"54","author":"Lips","year":"2022","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.cpsurg.2023.101361_bib0102","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.ccell.2022.10.021","article-title":"Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: analysis of TBCRC 038 and RAHBT cohorts","volume":"40","author":"Strand","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cpsurg.2023.101361_bib0103","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1130911","article-title":"Transcriptome analysis reveals differences in cell cycle, growth and migration related genes that distinguish fibroblasts derived from pre-invasive and invasive breast cancer","volume":"13","author":"Fang","year":"2023","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.cpsurg.2023.101361_bib0104","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00130404-200301000-00004","article-title":"Mammographic screening: a key factor in the control of breast cancer","volume":"9","author":"Tab\u00e1r","year":"2003","journal-title":"Cancer J"},{"issue":"4","key":"10.1016\/j.cpsurg.2023.101361_bib0105","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jamcollsurg.2005.05.032","article-title":"Image-detected breast cancer: state of the art diagnosis and treatment","volume":"201","author":"Silverstein","year":"2005","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.cpsurg.2023.101361_bib0106","unstructured":"American Cancer Society. American cancer society breast cancer facts and figures 2011. Accessed December 9, 2021. http:\/\/www.cancer.org\/research\/cancerfactsstatistics\/acspc-046381."},{"issue":"11","key":"10.1016\/j.cpsurg.2023.101361_bib0107","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1038\/bjc.2013.177","article-title":"The benefits and harms of breast cancer screening: an independent review","volume":"108","author":"Marmot","year":"2013","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.cpsurg.2023.101361_bib0108","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.7326\/0003-4819-127-11-199712010-00014","article-title":"Using autopsy series to estimate the disease \u201cReservoir\u201d for ductal carcinoma in situ of the breast: how much more breast cancer can we find?","volume":"127","author":"Welch","year":"1997","journal-title":"Ann Internal Med"},{"key":"10.1016\/j.cpsurg.2023.101361_bib0109","first-page":"88","article-title":"New aspects of the natural history of in situ and invasive carcinoma in the female breast. Results from autopsy investigations","volume":"69","author":"Andersen","year":"1985","journal-title":"Verh Dtsch Ges Pathol"},{"key":"10.1016\/j.cpsurg.2023.101361_bib0110","series-title":"Early Breast Cancer: From Screening to Multidisciplinary Management 3rd Edition","article-title":"The biological basis for breast cancer screening","author":"Benson","year":"2013"},{"key":"10.1016\/j.cpsurg.2023.101361_bib0111","doi-asserted-by":"crossref","first-page":"b957","DOI":"10.1136\/bmj.b957","article-title":"Will ductal carcinoma in situ defeat breast cancer screening?","volume":"338","author":"Benson","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.cpsurg.2023.101361_bib0112","series-title":"Overdiagnosed: Making People Sick in the Pursuit of Health","author":"Welch","year":"2012"},{"issue":"9855","key":"10.1016\/j.cpsurg.2023.101361_bib0113","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/S0140-6736(12)61611-0","article-title":"Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review","volume":"380","year":"2012","journal-title":"The Lancet"},{"key":"10.1016\/j.cpsurg.2023.101361_bib0114","unstructured":"Jeevan R, Cromwell D, Browne J, van der Meulen J. National mastectomy and breast reconstruction audit 2011. Accessed May 4, 2023. https:\/\/associationofbreastsurgery.org.uk\/media\/1085\/nmbra-annual-report-2011.pdf."},{"issue":"3","key":"10.1016\/j.cpsurg.2023.101361_bib0115","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jama.1991.03460030097037","article-title":"Treatment of early-stage breast cancer","volume":"265","year":"1991","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.cpsurg.2023.101361_bib0116","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/1097-0142(19840301)53:5<1209::AID-CNCR2820530531>3.0.CO;2-Y","article-title":"Conservative treatment versus mastectomy in breast cancer tumors with macroscopic diameter of 20 millimeters or less. The experience of the Institut Gustave-Roussy","volume":"53","author":"Sarrazin","year":"1984","journal-title":"Cancer"},{"issue":"4-5","key":"10.1016\/j.cpsurg.2023.101361_bib0117","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0959-8049(92)90118-L","article-title":"Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer","volume":"28a","author":"van Dongen","year":"1992","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.cpsurg.2023.101361_bib0118","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1056\/NEJM198107023050102","article-title":"Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast","volume":"305","author":"Veronesi","year":"1981","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.cpsurg.2023.101361_bib0119","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer","volume":"347","author":"Fisher","year":"2002","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.cpsurg.2023.101361_bib0120","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S1470-2045(12)70042-6","article-title":"Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial","volume":"13","author":"Liti\u00e8re","year":"2012","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.cpsurg.2023.101361_bib0121","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(12)70074-8","article-title":"Long-term outcome of breast conserving therapy","volume":"13","author":"Benson","year":"2012","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.cpsurg.2023.101361_bib0122","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S1470-2045(16)30067-5","article-title":"10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study","volume":"17","author":"van Maaren","year":"2016","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.cpsurg.2023.101361_bib0123","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1056\/NEJMsb1202521","article-title":"Surgical margins in lumpectomy for breast cancer\u2013bigger is not better","volume":"367","author":"Morrow","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.cpsurg.2023.101361_bib0124","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0002-9610(02)01012-7","article-title":"Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy","volume":"184","author":"Singletary","year":"2002","journal-title":"Am J Surg"},{"issue":"2","key":"10.1016\/j.cpsurg.2023.101361_bib0125","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1308\/003588407X155473","article-title":"A review of current practices in breast conservation surgery in the UK","volume":"89","author":"Young","year":"2007","journal-title":"Ann R Coll Surg Engl"},{"issue":"5","key":"10.1016\/j.cpsurg.2023.101361_bib0126","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jamcollsurg.2009.07.026","article-title":"Attaining negative margins in breast-conservation operations: is there a consensus among breast surgeons?","volume":"209","author":"Blair","year":"2009","journal-title":"J Am Coll Surg"},{"issue":"4","key":"10.1016\/j.cpsurg.2023.101361_bib0127","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/01.sla.0000157272.04803.1b","article-title":"Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey","volume":"241","author":"Taghian","year":"2005","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.cpsurg.2023.101361_bib0128","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1504473","article-title":"A randomized, controlled trial of cavity shave margins in breast cancer","volume":"373","author":"Chagpar","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.cpsurg.2023.101361_bib0129","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.amjsurg.2004.06.030","article-title":"Analysis of the use of specimen mammography in breast conservation therapy","volume":"188","author":"McCormick","year":"2004","journal-title":"Am J Surg"},{"issue":"18","key":"10.1016\/j.cpsurg.2023.101361_bib0130","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/j.ejca.2010.07.043","article-title":"Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy","volume":"46","author":"Houssami","year":"2010","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.cpsurg.2023.101361_bib0131","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1245\/s10434-014-3480-5","article-title":"The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis","volume":"21","author":"Houssami","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"14","key":"10.1016\/j.cpsurg.2023.101361_bib0132","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1200\/JCO.2013.53.3935","article-title":"Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer","volume":"32","author":"Moran","year":"2014","journal-title":"J Clin Oncol"},{"issue":"7520","key":"10.1016\/j.cpsurg.2023.101361_bib0133","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/bmj.331.7520.789","article-title":"An adequate margin of excision in ductal carcinoma in situ","volume":"331","author":"Kell","year":"2005","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.cpsurg.2023.101361_bib0134","first-page":"193","article-title":"Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications","volume":"11","author":"Faverly","year":"1994","journal-title":"Semin Diagn Pathol"},{"issue":"10","key":"10.1016\/j.cpsurg.2023.101361_bib0135","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1200\/JCO.2008.17.5182","article-title":"Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ","volume":"27","author":"Dunne","year":"2009","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.cpsurg.2023.101361_bib0136","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1245\/s10434-016-5446-2","article-title":"The association of surgical margins and local recurrence in women with ductal carcinoma in situ treated with breast-conserving therapy: a meta-analysis","volume":"23","author":"Marinovich","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.cpsurg.2023.101361_bib0137","unstructured":"NICE. Early and locally advanced breast cancer: diagnosis and treatment CG80. Accessed January 1, 2016. https:\/\/www.nice.org.uk\/guidance\/cg80."},{"key":"10.1016\/j.cpsurg.2023.101361_bib0138","doi-asserted-by":"crossref","first-page":"e4505","DOI":"10.1136\/bmj.e4505","article-title":"Reoperation rates after breast conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics","volume":"345","author":"Jeevan","year":"2012","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.cpsurg.2023.101361_bib0139","first-page":"3","article-title":"Volume replacement and displacement techniques in oncoplastic surgery","volume":"5","author":"Benson","year":"2008","journal-title":"Adv Breast Cancer"},{"issue":"2","key":"10.1016\/j.cpsurg.2023.101361_bib0140","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/SAP.0b013e3182605598","article-title":"A meta-analysis comparing breast conservation therapy alone to the oncoplastic technique","volume":"72","author":"Losken","year":"2014","journal-title":"Ann Plast Surg"},{"issue":"5","key":"10.1016\/j.cpsurg.2023.101361_bib0141","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ejso.2012.02.186","article-title":"How safe is oncoplastic breast conservation? Comparative analysis with standard breast conserving surgery","volume":"38","author":"Chakravorty","year":"2012","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.cpsurg.2023.101361_bib0142","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/tbj.12047","article-title":"Oncological advantages of oncoplastic breast-conserving surgery in treatment of early breast cancer","volume":"19","author":"Down","year":"2013","journal-title":"Breast J"},{"issue":"1","key":"10.1016\/j.cpsurg.2023.101361_bib0143","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(10)70266-7","article-title":"Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\/ANZ DCIS trial","volume":"12","author":"Cuzick","year":"2011","journal-title":"Lancet Oncol"},{"issue":"9503","key":"10.1016\/j.cpsurg.2023.101361_bib0144","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cpsurg.2023.101361_bib0145","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1200\/JCO.1998.16.2.441","article-title":"Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17","volume":"16","author":"Fisher","year":"1998","journal-title":"J Clin Oncol"},{"issue":"9169","key":"10.1016\/j.cpsurg.2023.101361_bib0146","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(99)05036-9","article-title":"Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial","volume":"353","author":"Fisher","year":"1999","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.cpsurg.2023.101361_bib0147","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2267::AID-CNCR13>3.0.CO;2-V","article-title":"A prognostic index for ductal carcinoma in situ of the breast","volume":"77","author":"Silverstein","year":"1996","journal-title":"Cancer"},{"issue":"19","key":"10.1016\/j.cpsurg.2023.101361_bib0148","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJM199905133401902","article-title":"The influence of margin width on local control of ductal carcinoma in situ of the breast","volume":"340","author":"Silverstein","year":"1999","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.cpsurg.2023.101361_bib0149","first-page":"167","article-title":"Ductal carcinoma in situ: a proposal for a new classification","volume":"11","author":"Holland","year":"1994","journal-title":"Semin Diagn Pathol"},{"issue":"7","key":"10.1016\/j.cpsurg.2023.101361_bib0150","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1200\/JCO.2005.02.9975","article-title":"Prospective study of wide excision alone for ductal carcinoma in situ of the breast","volume":"24","author":"Wong","year":"2006","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.cpsurg.2023.101361_bib0151","doi-asserted-by":"crossref","first-page":"122","DOI":"10.6004\/jnccn.2009.0012","article-title":"Breast cancer. Clinical practice guidelines in oncology","volume":"7","author":"Carlson","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"issue":"12","key":"10.1016\/j.cpsurg.2023.101361_bib0152","doi-asserted-by":"crossref","first-page":"djv263","DOI":"10.1093\/jnci\/djv263","article-title":"Trends in treatment patterns and outcomes for ductal carcinoma in situ","volume":"107","author":"Worni","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"32","key":"10.1016\/j.cpsurg.2023.101361_bib0153","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1200\/JCO.2009.21.8560","article-title":"Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group","volume":"27","author":"Hughes","year":"2009","journal-title":"J Clin Oncol"},{"issue":"10237","key":"10.1016\/j.cpsurg.2023.101361_bib0154","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.cpsurg.2023.101361_bib0155","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1200\/JCO.2010.34.0141","article-title":"Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24","volume":"30","author":"Allred","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cpsurg.2023.101361_bib0156","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejca.2018.06.027","article-title":"Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project","volume":"101","author":"Thompson","year":"2018","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.cpsurg.2023.101361_bib0157","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1016\/S1470-2045(13)70135-9","article-title":"Predictors of recurrence for ductal carcinoma in situ after breast-conserving surgery","volume":"14","author":"Benson","year":"2013","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.cpsurg.2023.101361_bib0158","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1073\/pnas.0931261100","article-title":"Gene expression profiles of human breast cancer progression","volume":"100","author":"Ma","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3a","key":"10.1016\/j.cpsurg.2023.101361_bib0159","first-page":"2043","article-title":"Gene expression profiling of ductal carcinomas in situ and invasive breast tumors","volume":"23","author":"Seth","year":"2003","journal-title":"Anticancer Res"},{"issue":"10","key":"10.1016\/j.cpsurg.2023.101361_bib0160","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1016\/S1470-2045(16)30367-9","article-title":"Treatment of low-risk ductal carcinoma in situ: is nothing better than something?","volume":"17","author":"Benson","year":"2016","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.cpsurg.2023.101361_bib0161","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","article-title":"Breast cancer mortality after a diagnosis of ductal carcinoma in situ","volume":"1","author":"Narod","year":"2015","journal-title":"JAMA Oncology"},{"issue":"8","key":"10.1016\/j.cpsurg.2023.101361_bib0162","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jamasurg.2015.0876","article-title":"Survival benefit of breast surgery for low-grade ductal carcinoma in situ: a population-based cohort study","volume":"150","author":"Sagara","year":"2015","journal-title":"JAMA Surg"},{"issue":"16","key":"10.1016\/j.cpsurg.2023.101361_bib0163","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","article-title":"Addressing overtreatment of screen detected DCIS; the LORIS trial","volume":"51","author":"Francis","year":"2015","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.cpsurg.2023.101361_bib0164","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026797","article-title":"The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)","volume":"9","author":"Hwang","year":"2019","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.cpsurg.2023.101361_bib0165","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","article-title":"Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ \u2013 The LORD study","volume":"51","author":"Elshof","year":"2015","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.cpsurg.2023.101361_bib0166","doi-asserted-by":"crossref","first-page":"djv290","DOI":"10.1093\/jnci\/djv290","article-title":"Addressing overtreatment in DCIS: what should physicians do now?","volume":"107","author":"Morrow","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.cpsurg.2023.101361_bib0167","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1586\/14737140.2015.1043897","article-title":"Ductal carcinoma in situ: treatment or active surveillance?","volume":"15","author":"Kuerer","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"issue":"13","key":"10.1016\/j.cpsurg.2023.101361_bib0168","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1245\/s10434-016-5595-3","article-title":"Women with low-risk DCIS eligible for the LORIS trial after complete surgical excision: how low is their risk after standard therapy?","volume":"23","author":"Pilewskie","year":"2016","journal-title":"Ann Surg Oncol"}],"container-title":["Current Problems in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011384023000989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011384023000989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T22:55:03Z","timestamp":1692226503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011384023000989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":168,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0011384023000989"],"URL":"https:\/\/doi.org\/10.1016\/j.cpsurg.2023.101361","relation":{},"ISSN":["0011-3840"],"issn-type":[{"value":"0011-3840","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Biology and Management of Ductal Carcinoma in Situ of the Breast","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpsurg.2023.101361","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101361"}}